Skip to main content
High RiskFDAfda-F-1127-2024OTHER

Onion Yellow Med 3 Outer Rings 4-5 LB in a 5 LB ,vacuum sealed, clear plastic bag. Labeling: White paper label with the following informa...

Category
Units Affected
23
Recall Date
March 27, 2024
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1127-2024.

The firm did not complete a hazard analysis for potential C. botulinum growth and toxin production of its processing, storage and shipping of raw onions into vacuum sealed bags.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1127-2024.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Pueblo Fruits, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1127-2024.

Pueblo Fruits, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Pueblo Fruits, Inc. Recall FAQ

Pueblo Fruits, Inc. is the subject of a produce safety report: Onion Yellow Med 3 Outer Rings 4-5 LB in a 5 LB ,vacuum sealed, clear plastic bag. Labeling: White paper label with the following informa.... The notice was published on March 27, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 23 units are potentially affected.